The FTC is challenging ‘junk’ drug patents. Here’s what they are and why they matter

The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time,…

Wegovy sales surge, COVID vax sales sink, and ‘junk’ patents: Pharma news roundup

Novo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’…

Ozempic and 19 other drugs have ‘junk’ patents, the FTC says in a new challenge

The U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent…

This femtech startup is unleashing AI on fetal ultrasounds

To assess the health of a fetus, sonographers and prenatal clinicians sift through a sprawl of…

Is now the right time to buy Keurig Dr. Pepper stock? | Smart Investing

Read more… Originally published on Quartz : Original article